Technology, Healthcare, Industrials Jan 19, 2022 05:30 PM (GMT+8) · EqualOcean
According to the announcement of Aoxiang pharmaceutical, the net profit in 2021 is expected to be 131-148 million yuan, with a year-on-year increase of 50.86% - 70.44%. Cdmo business and characteristic API business have achieved rapid growth. The expansion of new customers and the large volume of important products have driven the rapid growth of the company's profits.

This text is a result of machine translation.